Matches in DBpedia 2016-04 for { ?s ?p "Evolocumab (INN, trade name Repatha) is a monoclonal antibody designed for the treatment of hyperlipidemia by Amgen. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9).PCSK9 is a protein that targets LDL receptors for degradation and thereby reduces the liver's ability to remove LDL-C, or \"bad\" cholesterol, from the blood.Evolocumab is designed to bind to PCSK9 and inhibit PCSK9 from binding to LDL receptors on the liver surface."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Evolocumab comment "Evolocumab (INN, trade name Repatha) is a monoclonal antibody designed for the treatment of hyperlipidemia by Amgen. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9).PCSK9 is a protein that targets LDL receptors for degradation and thereby reduces the liver's ability to remove LDL-C, or \"bad\" cholesterol, from the blood.Evolocumab is designed to bind to PCSK9 and inhibit PCSK9 from binding to LDL receptors on the liver surface.".